参考文献 [1] 中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南第三版(2015版)[J]．中华临床感染病杂志，2015，8(5):385-401. DOI: 10.3760/cma.j.issn.1674-2397.2015.05.001. Society of
Infectious Diseases, Chinese Medical Association. Third edition of the
guidelines for diagnosis and treatment of HIV/AIDS (2015)[J]. Chin J Clin
Infect Dis, 2015, 8(5):385-401. DOI: 10.3760/cma.j.issn.1674-2397.2015.05.001.(in Chinese) [2] World Health
Organization. WHO HIV update: global epidemic and progress in scale up and
policy uptake[EB/OL]．[2018-09-30].
http://www.who.int/hiv/data/en/. [3] World Health
Organization. Global scientific leaders explore strategies to achieve the
90-90-90 target[EB/OL]．(2015-07-22)[2018-09-29]．http://www.unaids.org/en/resources/presscentre/featurestories/2015/july/20150722_90-90-90-target. [4] 吴尊友. 我国艾滋病经性传播新特征与防治面临的挑战[J]．中华流行病学杂志，2018，39(6):707-709.
DOI: 10.3760/cma.j.issn.0254-6450.2018.06.002. WuZY.
Characteristics of HIV sexually transmission and challenges for controlling the
epidemic in China[J]. Chin J Epidemiol, 2018, 39(6):707-709. DOI: 10.3760/cma.j.issn.0254-6450.2018.06.002. (in Chinese) [5] 中国疾病预防控制中心. 全国艾滋病检测技术规范(2015年修订版)[J]．中国病毒病杂志，2016，6(6):401-427. Chinese Center for
Control and Prevention. National guideline for detection of HIV/AIDS(2015)[J].
Chin J Viral Dis, 2016, 6(6):401-427. (in Chinese) [6] 荆凡辉，吕玮，李太生.
HIV感染者免疫功能重建新视角：CD4/CD8比值[J]．中国艾滋病性病，2018，24(6):643-646. JingFH, LyuW, LiTS.
A new view of CD4/CD8 ratio as an immune reconstitution marker in HIV-infected
individuals[J]. Chin J AIDS STD, 2018, 24(6):643-646. (in Chinese) [7] LiY, HanY, XieJ, et
al. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in
Chinese patients infected through sexual transmission[J]. AIDS, 2014,
28(4):521-530. DOI: 10.1097/QAD.0000000000000125. [8] SuB, MoogC. Which
antibody functions are important for an HIV vaccine？[J]. Front Immunol, 2014, 5:289. DOI: 10.3389/fimmu.2014.00289. [9] Panel on
Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for
the prevention and treatment of opportunistic infections in HIV-infected adults
and adolescents: recommendations from the Centers for Disease Control and
Prevention, the National Institutes of Health, and the HIV Medicine Association
of the Infectious Diseases Society of America[EB/OL]. [2018-10-02]．http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. [10] 卢洪洲. 艾滋病及其相关疾病临床路径[M]. 2版. 上海：上海科学技术出版社，2015. LuHZ. Clinical
pathways for AIDS and related diseases[M]. 2nd ed. Shanghai: Shanghai
Scientific &Technical Publishers, 2015. (in Chinese) [11] SelwynPA,
PumerantzAS, DuranteA, et al. Clinical predictors of Pneumocystis carinii
pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients[J].
AIDS, 1998, 12(8):885-893. [12] HidalgoA, FalcóV,
MauleónS, et al. Accuracy of high-resolution CT in distinguishing between
Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS
patients[J]. Eur Radiol, 2003, 13(5):1179-1184. DOI: 10.1007/s00330-002-1641-6. [13] RogerPM, VandenbosF,
PuglieseP, et al. Persistence of Pneumocystis carinii after effective treatment
of P. carinii pneumonia is not related to relapse or survival among patients
infected with human immunodeficiency virus[J]. Clin Infect Dis, 1998,
26(2):509-510. [14] SafrinS,
FinkelsteinDM, FeinbergJ, et al. Comparison of three regimens for treatment of
mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A
double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole,
dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group[J]. Ann
Intern Med, 1996, 124(9):792-802. [15] 中华医学会感染病学分会艾滋病学组，中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识[J]．中华临床感染病杂志，2017，10(2):81-90. DOI: 10.3760/cma.j.issn.1674-2397.2017.02.001. AIDS Professional
Group, Society of Infectious Diseases of Chinese Medical Association and AIDS
Professional Group, Society of Tropical Diseases and Parasitology of Chinese
Medical Association. Expert consensus on diagnosis and treatment of HIV
infection combined with Mycobacterium tuberculosis infection[J]. Chin J Clin
Infect Dis, 2017, 10(2):81-90. DOI: 10.3760/cma.j.issn.1674-2397.2017.02.001. (in Chinese) [16] Panel on
Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of
antiretroviral agents in adults and adolescents living with HIV. Department of
Health and Human Services[EB/OL]. [2018-10-02].
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. [17] European AIDS Clinical
Society. EACS Guidelines(Version 9.0)[EB/OL]. [2018-10-02].
http://www.eacsociety.org/files/guidelines_9.0-english.pdf. [18] World Health
Organization. Consolidated guidelines on the use of antiretroviral drugs for
treating and preventing HIV infection: recommendations for a public health
approach 2nd ed[EB/OL]. [2018-10-02].
http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=B2870D2288B92D29DBD1158E8D25E207?sequence=1. [19] ChenJ, ZhangR,
WangJ, et al. Interferon-gamma release assays for the diagnosis of active
tuberculosis in HIV-infected patients: a systematic review and
meta-analysis[J/OL]. PLoS One, 2011, 6(11):e26827. DOI: 10.1371/journal.pone.0026827. [20] ChenJ, SunJ, ZhangR,
et al. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected
patients with advanced immunodeficiency[J]. AIDS Res Hum Retroviruses, 2011,
27(3):289-294. DOI: 10.1089/aid.2010.0062. [21] PappasPG,
KauffmanCA, AndesDR, et al. Clinical practice guideline for the management of
candidiasis: 2016 Update by the Infectious Diseases Society of America[J]. Clin
Infect Dis, 2016, 62(4):e1-50. DOI: 10.1093/cid/civ933. |
